Researchers track evolution of HIV antibody

Researchers at the Duke University School of Medicine tracked the evolution of a broadly neutralizing antibody that recognizes different HIV strains, which could lead to the design of a vaccine. Broadly neutralizing antibodies are typically produced after the patient's HIV population has diversified, researchers reported online in Nature.

View Full Article in:

Nature (free content) · New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park